X-38403698-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000531.6(OTC):​c.621C>T​(p.Ser207Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000381 in 1,206,826 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 13 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000054 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000037 ( 0 hom. 13 hem. )

Consequence

OTC
NM_000531.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0490

Publications

6 publications found
Variant links:
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]
OTC Gene-Disease associations (from GenCC):
  • ornithine carbamoyltransferase deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant X-38403698-C-T is Benign according to our data. Variant chrX-38403698-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 368259.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.049 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0000536 (6/111874) while in subpopulation EAS AF = 0.0014 (5/3564). AF 95% confidence interval is 0.000552. There are 0 homozygotes in GnomAd4. There are 0 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAdExome4 at 13 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000531.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OTC
NM_000531.6
MANE Select
c.621C>Tp.Ser207Ser
synonymous
Exon 6 of 10NP_000522.3
OTC
NM_001407092.1
c.621C>Tp.Ser207Ser
synonymous
Exon 8 of 12NP_001394021.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OTC
ENST00000039007.5
TSL:1 MANE Select
c.621C>Tp.Ser207Ser
synonymous
Exon 6 of 10ENSP00000039007.4
ENSG00000250349
ENST00000465127.1
TSL:5
c.172-262423C>T
intron
N/AENSP00000417050.1
OTC
ENST00000713758.1
c.621C>Tp.Ser207Ser
synonymous
Exon 8 of 12ENSP00000519059.1

Frequencies

GnomAD3 genomes
AF:
0.0000537
AC:
6
AN:
111827
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00140
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000158
AC:
29
AN:
183103
AF XY:
0.000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000219
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00159
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000365
AC:
40
AN:
1094952
Hom.:
0
Cov.:
30
AF XY:
0.0000361
AC XY:
13
AN XY:
360506
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26346
American (AMR)
AF:
0.000284
AC:
10
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19357
East Asian (EAS)
AF:
0.000828
AC:
25
AN:
30188
South Asian (SAS)
AF:
0.0000370
AC:
2
AN:
54077
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40527
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4124
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
839137
Other (OTH)
AF:
0.0000435
AC:
2
AN:
45994
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000536
AC:
6
AN:
111874
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34070
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30812
American (AMR)
AF:
0.00
AC:
0
AN:
10532
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2639
East Asian (EAS)
AF:
0.00140
AC:
5
AN:
3564
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2664
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6080
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53158
Other (OTH)
AF:
0.00
AC:
0
AN:
1524
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000680
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ornithine carbamoyltransferase deficiency Benign:4
Dec 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

Jan 08, 2024
All of Us Research Program, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 21, 2022
Color Diagnostics, LLC DBA Color Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Jan 31, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
4.3
DANN
Benign
0.83
PhyloP100
-0.049
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72558415; hg19: chrX-38262951; COSMIC: COSV50005292; COSMIC: COSV50005292; API